ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.520
-0.005 (-0.20%)
Jun 27, 2025, 4:35 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 12.09 million as of June 27, 2025. Its market cap has increased by 22.02% in one year.
Market Cap
12.09M
Enterprise Value
11.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.52
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 12.09M, a decrease of -66.51%. That is a compound annual growth rate of -5.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.91B |
| GSK plc | 56.45B |
| Haleon | 34.45B |
| Smith & Nephew | 9.59B |
| ConvaTec Group | 5.93B |
| Hikma Pharmaceuticals | 4.49B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.26B |